Medicamen Biotech posts Rs. 3.64 Cr consolidated PAT in Q4FY21
News

Medicamen Biotech posts Rs. 3.64 Cr consolidated PAT in Q4FY21

The company has posted net profit of Rs.12.12 crores for the 12 months period ended March 31, 2021

  • By IPP Bureau | June 27, 2021

Medicamen Biotech has reported total income of Rs.21.77 crores during the period ended March 31, 2021 as compared to Rs.32.92 crores during the period ended December 31, 2020. The company reported total income of Rs.24.62 crores during the period ended March 31, 2020.

The company has posted net profit of Rs.3.64 crores for the period ended March 31, 2021 as against net profit of Rs.3.01 crores for the period ended December 31, 2020.It posted net profitof Rs.2.49 crores for the period ended March 31, 2020.

Medicamen Biotech has reported total income of Rs.113.47 crores during the 12 months period ended March 31, 2021 as compared to Rs.127.44 crores during the 12 months period ended March 31, 2020.

The company has posted net profit of Rs.12.12 crores for the 12 months period ended March 31, 2021 as against net profit of Rs.13.29 crores for the 12 months period ended March 31, 2020.

Upcoming E-conference

Other Related stories

Startup

Digitization